Clinical Trial Update: Prospective Validation of an EHR-based Pancreatic Cancer Risk Model

View source ↗

Summary

Prospective validation of an electronic health record–based model to predict pancreatic cancer risk. The trial is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma

Snippet

Sponsor: Beth Israel Deaconess Medical Center | Conditions: Pancreatic Adenocarcinoma, Predictive Cancer Model | Status: ACTIVE_NOT_RECRUITING